SIGN UPLog In

Last deal

$35M

Amount

Series A

Stage

31.03.2023

Date

2

all rounds

$35M

Total amount

General

About Company
Capacity Bio develops advanced mitophagy therapeutics and a platform to restore mitochondrial quality control in disease.

Industry

Sector :

Subsector :

Also Known As

Capacity

founded date

01.01.2021

Number of employees

1-10

Company Type

For Profit

Last funding type

Series A

IPO status

Private

Description

Capacity Bio is a therapeutics company that is focused on mitophagy. Capacity Bio is developing the most comprehensive and advanced mitophagy therapeutics and development platform for the purpose of restoring mitochondrial quality control in disease.
Contacts

location

Palo Alto, CA, USA

Phone number

Website URL

https://www.capacitybio.com/

Social url